» Articles » PMID: 38892280

Circular RNAs in Cell Cycle Regulation of Cancers

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Jun 19
PMID 38892280
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer has been one of the most problematic health issues globally. Typically, all cancers share a common characteristic or cancer hallmark, such as sustaining cell proliferation, evading growth suppressors, and enabling replicative immortality. Indeed, cell cycle regulation in cancer is often found to be dysregulated, leading to an increase in aggressiveness. These dysregulations are partly due to the aberrant cellular signaling pathway. In recent years, circular RNAs (circRNAs) have been widely studied and classified as one of the regulators in various cancers. Numerous studies have reported that circRNAs antagonize or promote cancer progression through the modulation of cell cycle regulators or their associated signaling pathways, directly or indirectly. Mostly, circRNAs are known to act as microRNA (miRNA) sponges. However, they also hold additional mechanisms for regulating cellular activity, including protein binding, RNA-binding protein (RBP) recruitment, and protein translation. This review will discuss the current knowledge of how circRNAs regulate cell cycle-related proteins through the abovementioned mechanisms in different cancers.

Citing Articles

Targeting macrophage to myofibroblast transition by circ_0001103 for subretinal fibrosis treatment.

Zhang Q, Lu B, He L, Fang K, Zhu X, Chen T J Transl Med. 2025; 23(1):251.

PMID: 40022123 PMC: 11871722. DOI: 10.1186/s12967-025-06173-3.


MicroRNA in prostate cancer: from biogenesis to applicative potential.

Luo X, Wen W BMC Urol. 2024; 24(1):244.

PMID: 39506720 PMC: 11539483. DOI: 10.1186/s12894-024-01634-1.

References
1.
Yip H, Papa A . Signaling Pathways in Cancer: Therapeutic Targets, Combinatorial Treatments, and New Developments. Cells. 2021; 10(3). PMC: 8002322. DOI: 10.3390/cells10030659. View

2.
Li X, Fang J, Wei G, Chen Y, Li D . accelerates the progression of hepatocellular carcinoma through the / axis. J Gastrointest Oncol. 2022; 13(4):1875-1888. PMC: 9459201. DOI: 10.21037/jgo-22-677. View

3.
Ye W, Chen L, Feng C, Liang T . CircMYLK promotes the growth, migration, invasion, and survival of bladder cancer cells by upregulating CCND3 level via competitively binding to miR-34a. Drug Dev Res. 2021; 82(8):1206-1216. DOI: 10.1002/ddr.21835. View

4.
Zhao J, Nie W, Dong L, Liu W, Wei W . A curcumin analog GL63 inhibits the malignant behaviors of hepatocellular carcinoma by inactivating the JAK2/STAT3 signaling pathway via the circular RNA zinc finger protein 83/microRNA-324-5p/cyclin-dependent kinase 16 axis. J Gastroenterol Hepatol. 2021; 36(10):2967-2977. PMC: 8518784. DOI: 10.1111/jgh.15545. View

5.
Liu Y, Lu C, Zhou Y, Zhang Z, Sun L . Circular RNA hsa_circ_0008039 promotes breast cancer cell proliferation and migration by regulating miR-432-5p/E2F3 axis. Biochem Biophys Res Commun. 2018; 502(3):358-363. DOI: 10.1016/j.bbrc.2018.05.166. View